Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 4/11/2025Eli Lilly Seeks Approval for Novel Breast Cancer Drug in China, Target...
  • 4/11/2025China Greenlights First Gene Therapy for Hemophilia B
  • 4/10/2025XellSmart's XS411 Receives IND Clearance in China for Parkinson's Dise...
  • 4/10/2025Novartis Files for New Indication of Long-Acting Cholesterol-Lowering ...
  • 4/10/2025Simcere's Anti-Tumor Candidate SIM0686 Gains Clinical Trial Approval i...
  • 4/10/2025ArkBio Completes Phase 3 Trial for AK0901 for ADHD in China 
  • 4/9/2025RemeGen Reports Positive Phase 3 Results for Telitacicept in gMG
  • 4/9/2025China Launches Phase I Trial for Nation's First Monkeypox Vaccine
  • 4/8/2025Akeso Initiates Investigator-Initiated Trial for Personalized mRNA Vac...
  • 4/5/2025Hansoh Initiates Phase 1 Trial for ADC Drug HS-20122 Targeting Advance...
  • 4/1/2025Biotheus Initiates Phase 3 Trial for BNT327/PM8002 in China
  • 4/1/2025Akeso Eyes U.S. Approval for Innovative Lung Cancer Therapy
  • 4/1/2025China Accelerates Brain Chip Trials After Initial Success
  • 3/31/2025Roche's Ocrevus Receives Chinese Approval for MS
  • 3/31/2025Hengrui Medicine Expands Phase 3 Trials for Oral GLP-1R Agonist HRS-75...
  • 3/31/2025BMS's Opdivo and Yervoy Combio Approved in China
  • 3/28/2025TaiMed Announces Results from Phase 2a Data on Long-Acting HIV Mainten...
  • 3/28/2025NiKang Thera Completes Dosing of the First Cohort in a Phase 1 Study ...
  • 3/28/2025AstraZeneca Advances AZD0120 CAR-T Trial for Lupus
  • 3/28/2025Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Pa...
  • 3/28/2025GenFleet Thera Reports Promising Phase II Results for Fulzerasib and C...
  • 3/28/2025Chinese Scientists Develop Breakthrough Vaccine Molecule to Enhance Im...
  • 3/27/2025NMPA Approves Suraxavir Marboxil for Influenza Treatment
  • 3/26/2025Ractigen's RAG-01 Shows Promising Early Complete Responses in Phase I ...
  • 3/25/2025Everest Announces FDA Clearance of IND Application for Tumor-Associate...
  • 3/25/2025BrightGene Initiates Phase II Head-to-Head Study of AI-Designed BGM050...
  • 3/24/2025FDA Rejects HLB Group's Liver Cancer Drug, Highlighting Regulatory and...
  • 3/24/2025SineuGene's SNUG01 Gene Therapy Receives FDA IND Approval for ALS Clin...
  • 3/24/2025GenScript's RA Drug Candidate Receives FDA Clearance for Clinical Tria...
  • 3/21/2025NMPA Approves Hutchmed's Tazverik for r/r Follicular Lymphoma in China
  • Page:1/11 Total number of articles:311: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group